Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods

References

• De JongJCWermenbolAGVerweij-UijterwaalMWAdenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectivelyJ Clin Microbiol199937123940394510565911
   PubMed Web of Science ®Google Scholar
• WadellGHammarskjoldMLWinbergGVarsanyiTMSundellGGenetic variability of adenovirusesAnn N Y Acad Sci1980354116426261642
   PubMedGoogle Scholar
• WalshMPSetoJJonesMSChodoshJXuWSetoDComputational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogenJ Clin Microbiol201048399199320042633
   PubMed Web of Science ®Google Scholar
• KanekoHAokiKOhnoSComplete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in JapanJ Clin Microbiol201149248449021147954
   PubMed Web of Science ®Google Scholar
• WallsTShankarAGShingadiaDAdenovirus: an increasingly important pathogen in paediatric bone marrow transplant patientsLancet Infect Dis200332798612560192
   PubMed Web of Science ®Google Scholar
• ZarragaALKernsFTKitchenLWAdenovirus pneumonia with severe sequelae in an immunocompetent adultClin Infect Dis19921547127131420689
   PubMed Web of Science ®Google Scholar
• FordENelsonKEWarrenEEpidemiology of epidemic keratoconjunctivitisEpidemiol Rev1987922442612824228
   PubMed Web of Science ®Google Scholar
• JerniganJALowryBSHaydenFGAdenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and controlJ Infect Dis19931676130713138501319
   PubMed Web of Science ®Google Scholar
• BordigoniPCarretASVenardVWitzFLe FaouATreatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantationClin Infect Dis20013291290129711303263
   PubMedGoogle Scholar
• GavinPJKatzBZIntravenous ribavirin treatment for severe adenovirus disease in immunocompromised childrenPediatrics20021101 Pt 11812093940
   PubMed Web of Science ®Google Scholar
• LankesterACHeemskerkBClaasECEffect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infectionClin Infect Dis200438111521152515156436
   PubMed Web of Science ®Google Scholar
• de OliveiraBStevensonDLaBreeLMcDonnelPJTrousdaleMDEvaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular modelAntiviral Res19963131651728811201
   PubMed Web of Science ®Google Scholar
• GordonYGRomanowskiEGAraullo-CruzTPInhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic-GMP on clinical ocular adenoviral isolates is serotype-dependent in vitroAntiviral Res199116111161776874
   PubMed Web of Science ®Google Scholar
• MentelRKinderMWegnerUJanta-LipinskiMMatthesEInhibitory activity of 3′-fluoro-2′-deoxythymidine and related nucleoside analogues against adenovirus in vitroAntiviral Res19973431131199191018
   PubMed Web of Science ®Google Scholar
• UchioEFuchigamiAKadonosonoKAnti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitisGraefes Arch Clin Exp Ophthalmol200724591319132517226023
   PubMed Web of Science ®Google Scholar
• HoffmanJAShahAJRossLAKapoorNAdenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantationBiol Blood Marrow Transplant20017738839411529489
   PubMed Web of Science ®Google Scholar
• TrousdaleMDNesburnABWilleyDETaaidHEfficacy of BW759 (9-[[2-hydroxy-l-(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbitsCurr Eye Res198438100710156333319
   PubMed Web of Science ®Google Scholar
• ColinJGanciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpesClin Ophthalmol20071444145319668521
   PubMedGoogle Scholar
• SmithKOGallowayKSKennellWLOgilvieKKRadatusBKA new nucleoside analog, 9-[[2-hydroxy-l(hydroxymethyl)ethoxy]methyl] guanine, highly active in vitro against herpes simplex virus types 1 and 2Antimicrob Agents Chemother198222155616289741
   PubMed Web of Science ®Google Scholar
• NaesensLLenaertsLAndreiGAntiadenovirus activities of several classes of nucleoside and nucleotide analoguesAntimicrob Agents Chemother20054931010101615728896
   PubMed Web of Science ®Google Scholar
• TrousdaleMDGoldschmidtPLNóbregaRActivity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyesCornea19941354354397995068
   PubMed Web of Science ®Google Scholar
• NodaMOtagakiYIkedaYMatsuishiTOginoTGenome types of adenovirus types 19 and 37 isolated from patients with conjunctivitis in Hiroshima CityJ Med Virol198826115222846769
   PubMed Web of Science ®Google Scholar
• Miura-OchiaiRShimadaYKonnoTQuantitative detection and rapid identification of human adenovirusesJ Clin Microbiol200745395896717229856
   PubMed Web of Science ®Google Scholar
• ZipperHBrunnerHBernhagenJVitzthumFInvestigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implicationsNucleic Acids Res20043212e10315249599
   PubMed Web of Science ®Google Scholar
• KanekoHSuzutaniTAokiKEpidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in JapanBr J Ophthalmol2011951323620530657
   PubMed Web of Science ®Google Scholar
• O’DonnellBMcCrudenEADesselbergerUMolecular epidemiology of adenovirus conjunctivitis in Glasgow 1981–1991Eye (Lond)19937Pt 3 Suppl8148253224
   PubMed Web of Science ®Google Scholar
• MorfinFDupuis-GirodSMundweilerSIn vitro susceptibility of adenovirus to antiviral drugs is species-dependentAntivir Ther200510222522915865216
   PubMed Web of Science ®Google Scholar
• UchioEInoueHKadonosonoKAntiadenoviral effects of N-chlorotaurine in vitro confirmed by quantitative polymerase chain reaction methodsClin Ophthalmol20101941325132921139673
   PubMedGoogle Scholar
• UchioEKimuraRHuangYHAnti-adenoviral effect of a5b1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitisOphthalmologica2007221532633017728555
   PubMed Web of Science ®Google Scholar
• FanourgiakisPGeorgalaAVekemansMIntravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipientClin Infect Dis200540119920115614713
   PubMed Web of Science ®Google Scholar
• LjungmanPTreatment of adenovirus infections in the immunocompromised hostEur J Clin Microbiol Infect Dis200423858358815248091
   PubMed Web of Science ®Google Scholar
• HillenkampJReinhardTRossRSThe effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot studyOphthalmology2002109584585011986086
   PubMed Web of Science ®Google Scholar
• BrunoBGooleyTHackmanRCDavisCCoreyLBoeckhMAdenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survivalBiol Blood Marrow Transplant20039534135212766884
   PubMed Web of Science ®Google Scholar
• WreghittTGGrayJJWardKNDisseminated adenovirus infection after liver transplantation and its possible treatment with ganciclovirJ Infect198919188892550558
   PubMed Web of Science ®Google Scholar
• DugganJMFarrehiJDuderstadtSTurnerNJFeketyRTreatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patientAm J Med199710354394409375714
   PubMed Web of Science ®Google Scholar
• ChenFELiangRHLoJYYuenKYChanTKPeirisMTreatment of adenovirus-associated haemorrhagic cystitis with ganciclovirBone Marrow Transplant199720119979999422482
   PubMed Web of Science ®Google Scholar
• KaufmanHEHawWHGanciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitisCurr Eye Res201237765466022607463
   PubMed Web of Science ®Google Scholar